EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Zuranolone therapy protects frontal cortex neurodevelopment and improves behavioral outcomes after preterm birth

Roisin A Moloney iD, Hannah K Palliser, Carlton L Pavy, Julia C Shaw, Jonathan J Hirst

Brain and Behavior · 2024

DOI: 10.1002/brb3.70009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Roisin A Moloney und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia. Hauptthemen laut MEDLINE: Pregnanolone, Premature Birth, Frontal Lobe. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preterm birth is associated with brain injury and long‐term behavioral abnormalities, for which there are limited prevention options. When born preterm, infants prematurely lose placental neurosteroid (allopregnanolone) support. This increases the risk of excitotoxic damage to the brain, which increases the risk of injury, causing long‐term deficits in behavior, myelination, and alterations to neurotransmitter pathways. We propose that postnatal restoration of neurosteroid action through zuranolone therapy will reduce neurological impairments following preterm birth.

Methods

Guinea pig dams underwent survival cesarean section surgery to deliver pups prematurely (GA64) or at term (GA69). Between birth and term equivalence age, preterm pups received vehicle (15% β‐cyclodextrin) or the allopregnanolone analogue zuranolone (1 mg/kg/day). Behavioral analysis was performed at postnatal day (PND) 7 and 40, before tissue collection at PND 42. Immunostaining for myelin basic protein (MBP), as well as real‐time polymerase chain reaction to characterize oligodendrocyte lineage and neurotransmitter pathways, was performed in frontal cortex tissues.

Results

Zuranolone treatment prevented the hyperactive phenotype in preterm‐born offspring, most markedly in males. Additionally, preterm‐related reductions in MBP were ameliorated. Several preterm‐related alterations in mRNA expression of dopaminergic, glutamatergic, and GABAergic pathways were also restored back to that of a term control level.

Conclusion

This is the first study to assess zuranolone treatment as a neuroprotective therapy following preterm birth. Zuranolone treatment improved behavioral outcomes and structural changes in the preterm offspring, which continued long term until at least a late childhood timepoint. Clinical studies are warranted for further exploring the neuroprotective possibilities of this treatment following preterm birth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PregnanolonePremature BirthFrontal LobeAnimalsFemaleGuinea PigsMaleAnimals, NewbornPregnancyBehavior, AnimalNeuroprotective AgentsOligodendrogliaMyelin Basic Protein

Stichwörter der Autor:innen

GABAbehaviordopamineneurosteroidpreterm birth

Substanzen

PregnanoloneNeuroprotective AgentsMyelin Basic Protein

Autor:innen und Institutionen

  • School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, Australia.
  • Hunter Medical Research Institute, Mothers and Babies Research Centre, Newcastle, Australia.

ORCID-Profile: Roisin A Moloney

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Moloney, R. A., Palliser, H. K., Pavy, C. L., Shaw, J. C., & Hirst, J. J. (2024). Zuranolone therapy protects frontal cortex neurodevelopment and improves behavioral outcomes after preterm birth. Brain and Behavior. https://doi.org/10.1002/brb3.70009

Vancouver

Moloney RA, Palliser HK, Pavy CL, Shaw JC, Hirst JJ. Zuranolone therapy protects frontal cortex neurodevelopment and improves behavioral outcomes after preterm birth. Brain and Behavior. 2024. doi:10.1002/brb3.70009

BibTeX
@article{Moloney2024,
  author = {Moloney, Roisin A and Palliser, Hannah K and Pavy, Carlton L and Shaw, Julia C and Hirst, Jonathan J},
  title = {Zuranolone therapy protects frontal cortex neurodevelopment and improves behavioral outcomes after preterm birth},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.70009}
}
Kostenlos starten →